Trial Profile
A pilot study to investigate the effects of allergen immunotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic rhinitis
- Focus Proof of concept; Therapeutic Use
- 30 Dec 2015 New trial record